Pancreatic Cancer Research

ResearcherUniversity of MichiganActive in the last 2 years

Imad Shureiqi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2019-938X; OpenAlex author ID A5020406311; NIH RePORTER profile ID 1953966. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
1
Labs led
1
Collaborators
10
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper, 1 grant

Papers 3

  1. PPARδ: An underappreciated tumor accelerator in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2026.218385↗
  2. Ppard Is Essential in Acceleration of Pancreatic Ductal Adenocarcinoma Development by High-Fat Diet in Mutant Kras Mice Last author DOI 10.1101/2020.12.04.412320↗
  3. Novel and emerging innate immune therapeutic targets for pancreatic cancer. First author DOI 10.1080/14728222.2018.1538361↗

Grants 1

  1. PPARD hyperactivation promotes pancreatic intraepithelial neoplasia progression into pancreatic ductal adenocarcinoma R01CA273732↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daoyan Wei · 3 shared papers, 2018–2026 · strength 0.57
  2. Yi Liu · 2 shared papers, 2020–2026 · strength 0.45
  3. Xiangsheng Zuo · 2 shared papers, 2020–2026 · strength 0.45
  4. James C. Yao · 2 shared papers, 2020–2026 · strength 0.45
  5. Danping Niu · 1 shared paper, 2026 · strength 0.36
  6. Liang Wang · 1 shared paper, 2018 · strength 0.12
  7. Huamin Wang · 1 shared paper, 2020 · strength 0.09
  8. Xiaofeng Zheng · 1 shared paper, 2020 · strength 0.09
  9. Baoan Ji · 1 shared paper, 2020 · strength 0.09
  10. Donghui Li · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.